GSK3-targeted small molecules as therapies for Alzheimer’s disease
<p style="margin-left:0cm; margin-right:0cm">Alzheimer’s disease (AD) is a progressive neurological disorder that affects memory, thinking, and behavior. It is one of the leading causes of dementia worldwide, and current treatments mainly focus on managing symptoms rather than slowing or stopping disease progress
Authors
- Krina Patel
Publication Details
- Journal
- European Journal of Biomedical and Life Sciences
- Published
- 2026-03-31
- DOI
- https://doi.org/10.29013/ejbls-26-1-33-45
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00